CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Age- and gender-related differences in SVR and relapse following treatment of HCV genotype 3 (G3) infection with Peginterferon alfa-2b (peg2b)/Ribavirin (RBV) in real-life
DOI 10.1055/s-0032-1332163
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Mauss, D Hüppe, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, D Hartmann, A Heuser, M Bilzer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Because of the current lack of direct antiviral drugs, improvement of HCV G3 treatment can be achieved only by optimization of dual therapy. Preliminary data suggest lower SVR rates for G3 infected elder patients. We therefore aimed to identify the contributing factors. Methods: Within a multicenter observational study in Germany 1328 of 4061 patients with chronic hepatitis C were infected with G3. Of th…
Zitieren
Zitierempfehlung
S Mauss, D Hüppe, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, D Hartmann, A Heuser, M Bilzer (2013) Age- and gender-related differences in SVR and relapse following treatment of HCV genotype 3 (G3) infection with Peginterferon alfa-2b (peg2b)/Ribavirin (RBV) in real-life. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0032-1332163
Mit CareLit weiterarbeiten